nmm 22 4500 ICPSR34565 MiAaI m f a u cr mn mmmmuuuu 130521s2013 miu f a eng d (MiAaI)ICPSR34565 MiAaI MiAaI Drug Abuse Warning Network (DAWN), 2011 [electronic resource] United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality 2013-05-02 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 2013 ICPSR 34565 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. The Drug Abuse Warning Network (DAWN) is a nationally representative public health surveillance system that has monitored drug related emergency department (ED) visits to hospitals since the early 1970s. First administered by the Drug Enforcement Administration (DEA) and the National Institute on Drug Abuse (NIDA), the responsibility for DAWN now rests with SAMHSA's Center for Behavioral Health Statistics and Quality (CBHSQ). Over the years, the exact survey methodology has been adjusted to improve the quality, reliability, and generalizability of the information produced by DAWN. The current approach was first fully implemented in the 2004 data collection year. DAWN relies on a longitudinal probability sample of hospitals located throughout the United States. To be eligible for selection into the DAWN sample, a hospital must be a non-Federal, short-stay, general surgical and medical hospital located in the United States, with at least one 24-hour ED. DAWN cases are identified by the systematic review of ED medical records in participating hospitals. The unit of analysis is any ED visit involving recent drug use. DAWN captures both ED visits that are directly caused by drugs and those in which drugs are a contributing factor but not the direct cause of the ED visit. The reason a patient used a drug is not part of the criteria for considering a visit to be drug-related. Therefore, all types of drug-related events are included: drug misuse or abuse, accidental drug ingestion, drug-related suicide attempts, malicious drug poisonings, and adverse reactions. DAWN does not report current medications (i.e., medications and pharmaceuticals taken regularly by the patient as prescribed or indicated) that are unrelated to the ED visit. The DAWN public-use dataset provides information for all types of drugs, including illegal drugs, prescription drugs, over-the-counter medications, dietary supplements, anesthetic gases, substances that have psychoactive effects when inhaled, alcohol when used in combination with other drugs (all ages), and alcohol alone (only for patients aged 20 or younger). Public-use dataset variables describe and categorize up to 22 drugs contributing to the ED visit, including toxicology confirmation and route of administration. Administrative variables specify the type of case, case disposition, categorized episode time of day, and quarter of year. Metropolitan area is included for represented metropolitan areas. Created variables include the number of unique drugs reported and case-level indicators for alcohol, non-alcohol illicit, any pharmaceutical, non-medical use of pharmaceuticals, and all misuse and abuse. Demographic items include age category, sex, and race/ethnicity. Complex sample design and weighting variables are included to calculate various estimates of drug-related ED visits for the Nation as a whole, as well as for specific metropolitan areas, from the ED visits classified as DAWN cases in the selected hospitals. Cf.: http://dx.doi.org/10.3886/ICPSR34565.v1 alcohol icpsr demographic characteristics icpsr detoxification icpsr drug overdose icpsr drug use icpsr emergency departments icpsr nonprescription drugs icpsr over-the-counter drugs icpsr substance abuse icpsr suicide icpsr SAMHDA VIII. Drug Abuse Warning Network (DAWN) ICPSR IX. Health Care and Health Facilities NAHDAP I. National Addiction and HIV Data Archive Program United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality Inter-university Consortium for Political and Social Research. ICPSR (Series) 34565 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR34565.v1 nmm 22 4500 ICPSR34481 MiAaI m f a u cr mn mmmmuuuu 130521s2012 miu f a eng d (MiAaI)ICPSR34481 MiAaI MiAaI National Survey on Drug Use and Health, 2011 [electronic resource] United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality 2013-03-28 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 2012 ICPSR 34481 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) primarily measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health-related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2011 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention-related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey. For the 2008 survey, adult mental health questions were added to measure symptoms of psychological distress in the worst period of distress that a person experienced in the past 30 days and suicidal ideation. In 2008, a split-sample design also was included to administer separate sets of questions (WHODAS vs. SDS) to assess impairment due to mental health problems. Beginning with the 2009 NSDUH, however, all of the adults in the sample received only the WHODAS questions. Background information includes gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition. Cf.: http://dx.doi.org/10.3886/ICPSR34481.v1 addiction icpsr alcohol icpsr alcohol abuse icpsr alcohol consumption icpsr amphetamines icpsr barbiturates icpsr cocaine icpsr controlled drugs icpsr crack cocaine icpsr demographic characteristics icpsr depression (psychology) icpsr drinking behavior icpsr drug abuse icpsr drug dependence icpsr drug treatment icpsr drug use icpsr drugs icpsr employment icpsr hallucinogens icpsr health care icpsr heroin icpsr households icpsr income icpsr inhalants icpsr marijuana icpsr mental health icpsr mental health services icpsr methamphetamine icpsr pregnancy icpsr prescription drugs icpsr sedatives icpsr smoking icpsr stimulants icpsr substance abuse icpsr substance abuse treatment icpsr tobacco use icpsr tranquilizers icpsr youths icpsr RCMD V. Health and Well-Being RCMD I. Crime SAMHDA I. National Survey on Drug Use and Health (NSDUH) NAHDAP I. National Addiction and HIV Data Archive Program DSDR III. Health ICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice System NACJD XI. Drugs, Alcohol, and Crime United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality Inter-university Consortium for Political and Social Research. ICPSR (Series) 34481 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR34481.v1 nmm 22 4500 ICPSR34083 MiAaI m f a u cr mn mmmmuuuu 130521s2012 miu f a eng d (MiAaI)ICPSR34083 MiAaI MiAaI Drug Abuse Warning Network (DAWN), 2010 [electronic resource] United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality 2012-09-27 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 2012 ICPSR 34083 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. The Drug Abuse Warning Network (DAWN) is a nationally representative public health surveillance system that has monitored drug related emergency department (ED) visits to hospitals since the early 1970s. First administered by the Drug Enforcement Administration (DEA) and the National Institute on Drug Abuse (NIDA), the responsibility for DAWN now rests with SAMHSA's Center for Behavioral Health Statistics and Quality (CBHSQ). Over the years, the exact survey methodology has been adjusted to improve the quality, reliability, and generalizability of the information produced by DAWN. The current approach was first fully implemented in the 2004 data collection year. DAWN relies on a longitudinal probability sample of hospitals located throughout the United States. To be eligible for selection into the DAWN sample, a hospital must be a non-Federal, short-stay, general surgical and medical hospital located in the United States, with at least one 24-hour ED. DAWN cases are identified by the systematic review of ED medical records in participating hospitals. The unit of analysis is any ED visit involving recent drug use. DAWN captures both ED visits that are directly caused by drugs and those in which drugs are a contributing factor but not the direct cause of the ED visit. The reason a patient used a drug is not part of the criteria for considering a visit to be drug-related. Therefore, all types of drug-related events are included: drug misuse or abuse, accidental drug ingestion, drug-related suicide attempts, malicious drug poisonings, and adverse reactions. DAWN does not report current medications (i.e., medications and pharmaceuticals taken regularly by the patient as prescribed or indicated) that are unrelated to the ED visit. The DAWN public-use dataset provides information for all types of drugs, including illegal drugs, prescription drugs, over-the-counter medications, dietary supplements, anesthetic gases, substances that have psychoactive effects when inhaled, alcohol when used in combination with other drugs (all ages), and alcohol alone (only for patients aged 20 or younger). Public-use dataset variables describe and categorize up to 22 drugs contributing to the ED visit, including toxicology confirmation and route of administration. Administrative variables specify the type of case, case disposition, categorized episode time of day, and quarter of year. Metropolitan area is included for represented metropolitan areas. Created variables include the number of unique drugs reported and case-level indicators for alcohol, non-alcohol illicit, any pharmaceutical, non-medical use of pharmaceuticals, and all misuse and abuse. Demographic items include age category, sex, and race/ethnicity. Complex sample design and weighting variables are included to calculate various estimates of drug-related ED visits for the Nation as a whole, as well as for specific metropolitan areas, from the ED visits classified as DAWN cases in the selected hospitals. Cf.: http://dx.doi.org/10.3886/ICPSR34083.v1 alcohol icpsr demographic characteristics icpsr detoxification icpsr drug overdose icpsr drug use icpsr emergency departments icpsr nonprescription drugs icpsr over-the-counter drugs icpsr substance abuse icpsr suicide icpsr ICPSR IX. Health Care and Health Facilities NAHDAP I. National Addiction and HIV Data Archive Program SAMHDA VIII. Drug Abuse Warning Network (DAWN) United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality Inter-university Consortium for Political and Social Research. ICPSR (Series) 34083 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR34083.v1 nmm 22 4500 ICPSR31921 MiAaI m f a u cr mn mmmmuuuu 130521s2011 miu f a eng d (MiAaI)ICPSR31921 MiAaI MiAaI Drug Abuse Warning Network (DAWN), 2009 [electronic resource] United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality 2012-01-24 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 2011 ICPSR 31921 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. The Drug Abuse Warning Network (DAWN) is a nationally representative public health surveillance system that has monitored drug related emergency department (ED) visits to hospitals since the early 1970s. First administered by the Drug Enforcement Administration (DEA) and the National Institute on Drug Abuse (NIDA), the responsibility for DAWN now rests with SAMHSA's Center for Behavioral Health Statistics and Quality (CBHSQ). Over the years, the exact survey methodology has been adjusted to improve the quality, reliability, and generalizability of the information produced by DAWN. The current approach was first fully implemented in the 2004 data collection year. DAWN relies on a longitudinal probability sample of hospitals located throughout the United States. To be eligible for selection into the DAWN sample, a hospital must be a non-Federal, short-stay, general surgical and medical hospital located in the United States, with at least one 24-hour ED. DAWN cases are identified by the systematic review of ED medical records in participating hospitals. The unit of analysis is any ED visit involving recent drug use. DAWN captures both ED visits that are directly caused by drugs and those in which drugs are a contributing factor but not the direct cause of the ED visit. The reason a patient used a drug is not part of the criteria for considering a visit to be drug-related. Therefore, all types of drug-related events are included: drug misuse or abuse, accidental drug ingestion, drug-related suicide attempts, malicious drug poisonings, and adverse reactions. DAWN does not report current medications (i.e., medications and pharmaceuticals taken regularly by the patient as prescribed or indicated) that are unrelated to the ED visit. The DAWN public-use dataset provides information for all types of drugs, including illegal drugs, prescription drugs, over-the-counter medications, dietary supplements, anesthetic gases, substances that have psychoactive effects when inhaled, alcohol when used in combination with other drugs (all ages), and alcohol alone (only for patients aged 20 or younger). Public-use dataset variables describe and categorize up to 22 drugs contributing to the ED visit, including toxicology confirmation and route of administration. Administrative variables specify the type of case, case disposition, categorized episode time of day, and quarter of year. Metropolitan area is included for represented metropolitan areas. Created variables include the number of unique drugs reported and case-level indicators for alcohol, non-alcohol illicit, any pharmaceutical, non-medical use of pharmaceuticals, and all misuse and abuse. Demographic items include age category, sex, and race/ethnicity. Complex sample design and weighting variables are included to calculate various estimates of drug-related ED visits for the Nation as a whole, as well as for specific metropolitan areas, from the ED visits classified as DAWN cases in the selected hospitals. Cf.: http://dx.doi.org/10.3886/ICPSR31921.v2 alcohol icpsr demographic characteristics icpsr detoxification icpsr drug overdose icpsr drug use icpsr emergency departments icpsr nonprescription drugs icpsr over-the-counter drugs icpsr substance abuse icpsr suicide icpsr NAHDAP I. National Addiction and HIV Data Archive Program ICPSR IX. Health Care and Health Facilities SAMHDA VIII. Drug Abuse Warning Network (DAWN) United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality Inter-university Consortium for Political and Social Research. ICPSR (Series) 31921 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR31921.v2 nmm 22 4500 ICPSR31264 MiAaI m f a u cr mn mmmmuuuu 130521s2011 miu f a eng d (MiAaI)ICPSR31264 MiAaI MiAaI Drug Abuse Warning Network (DAWN), 2008 [electronic resource] United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality 2012-01-24 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 2011 ICPSR 31264 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. The Drug Abuse Warning Network (DAWN) is a nationally representative public health surveillance system that has monitored drug related emergency department (ED) visits to hospitals since the early 1970s. First administered by the Drug Enforcement Administration (DEA) and the National Institute on Drug Abuse (NIDA), the responsibility for DAWN now rests with SAMHSA’s Center for Behavioral Health Statistics and Quality (CBHSQ). Over the years, the exact survey methodology has been adjusted to improve the quality, reliability, and generalizability of the information produced by DAWN. The current approach was first fully implemented in the 2004 data collection year. DAWN relies on a longitudinal probability sample of hospitals located throughout the United States. To be eligible for selection into the DAWN sample, a hospital must be a non-Federal, short-stay, general surgical and medical hospital located in the United States, with at least one 24-hour ED. DAWN cases are identified by the systematic review of ED medical records in participating hospitals. The unit of analysis is any ED visit involving recent drug use. DAWN captures both ED visits that are directly caused by drugs and those in which drugs are a contributing factor but not the direct cause of the ED visit. The reason a patient used a drug is not part of the criteria for considering a visit to be drug related. Therefore, all types of drug-related events are included: drug misuse or abuse, accidental drug ingestion, drug-related suicide attempts, malicious drug poisonings, and adverse reactions. DAWN does not report current medications (i.e., medications and pharmaceuticals taken regularly by the patient as prescribed or indicated) that are unrelated to the ED visit. The DAWN public-use dataset provides information for all types of drugs, including illegal drugs, prescription drugs, over-the-counter medications, dietary supplements, anesthetic gases, substances that have psychoactive effects when inhaled, alcohol when used in combination with other drugs (all ages), and alcohol alone (only for patients aged 20 or younger). Public-use dataset variables describe and categorize up to 16 drugs contributing to the ED visit, including toxicology confirmation and route of administration. Administrative variables specify the type of case, case disposition, categorized episode time of day, and quarter of year. Metropolitan area is included for represented metropolitan areas. Created variables include the number of unique drugs reported and case-level indicators for alcohol, non-alcohol illicit, any pharmaceutical, non-medical use of pharmaceuticals, and all misuse and abuse. Demographic items include age category, sex, and race/ethnicity. Complex sample design and weighting variables are included to calculate various estimates of drug-related ED visits for the Nation as a whole, as well as for specific metropolitan areas, from the ED visits classified as DAWN cases in the selected hospitals. Cf.: http://dx.doi.org/10.3886/ICPSR31264.v3 alcohol icpsr demographic characteristics icpsr detoxification icpsr drug overdose icpsr drug use icpsr emergency departments icpsr nonprescription drugs icpsr over-the-counter drugs icpsr substance abuse icpsr suicide icpsr ICPSR IX. Health Care and Health Facilities NAHDAP I. National Addiction and HIV Data Archive Program SAMHDA VIII. Drug Abuse Warning Network (DAWN) United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality Inter-university Consortium for Political and Social Research. ICPSR (Series) 31264 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR31264.v3 nmm 22 4500 ICPSR26701 MiAaI m f a u cr mn mmmmuuuu 130521s2009 miu f a eng d (MiAaI)ICPSR26701 MiAaI MiAaI National Survey on Drug Use and Health, 2008 [electronic resource] United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies 2012-12-10 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 2009 ICPSR 26701 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) primarily measures the prevalence and correlates of drug use in the United States. Detailed NSDUH 2008 documentation is available from SAMHSA. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2008 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention-related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey. For this 2008 survey, Adult mental health questions were added to measure symptoms of psychological distress in the worst period of distress that a person experienced in the past 30 days and suicidal ideation. A split-sample design also was included to administer separate sets of questions to assess impairment due to mental health problems. Background information includes gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition. Cf.: http://dx.doi.org/10.3886/ICPSR26701.v3 alcohol consumption icpsr amphetamines icpsr barbiturates icpsr cocaine icpsr controlled drugs icpsr crack cocaine icpsr demographic characteristics icpsr depression (psychology) icpsr drinking behavior icpsr drug abuse icpsr drug dependence icpsr drug treatment icpsr drug use icpsr drugs icpsr employment icpsr hallucinogens icpsr health care icpsr heroin icpsr households icpsr income icpsr inhalants icpsr marijuana icpsr mental health icpsr mental health services icpsr methamphetamine icpsr pregnancy icpsr prescription drugs icpsr sedatives icpsr smoking icpsr stimulants icpsr substance abuse icpsr substance abuse treatment icpsr tobacco use icpsr tranquilizers icpsr youths icpsr addiction icpsr alcohol icpsr alcohol abuse icpsr DSDR III. Health RCMD I. Crime NAHDAP I. National Addiction and HIV Data Archive Program RCMD V. Health and Well-Being SAMHDA I. National Survey on Drug Use and Health (NSDUH) ICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice System NACJD XI. Drugs, Alcohol, and Crime United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies Inter-university Consortium for Political and Social Research. ICPSR (Series) 26701 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR26701.v3 nmm 22 4500 ICPSR32861 MiAaI m f a u cr mn mmmmuuuu 130521s2012 miu f a eng d (MiAaI)ICPSR32861 MiAaI MiAaI Drug Abuse Warning Network (DAWN), 2007 [electronic resource] United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies 2012-01-26 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 2012 ICPSR 32861 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. The Drug Abuse Warning Network (DAWN) is a nationally representative public health surveillance system that has monitored drug related emergency department (ED) visits to hospitals since the early 1970s. First administered by the Drug Enforcement Administration (DEA) and the National Institute on Drug Abuse (NIDA), the responsibility for DAWN now rests with SAMHSA’s Center for Behavioral Health Statistics and Quality (CBHSQ). Over the years, the exact survey methodology has been adjusted to improve the quality, reliability, and generalizability of the information produced by DAWN. The current approach was first fully implemented in the 2004 data collection year. DAWN relies on a longitudinal probability sample of hospitals located throughout the United States. To be eligible for selection into the DAWN sample, a hospital must be a non-federal, short-stay, general surgical and medical hospital located in the United States, with at least one 24-hour ED. DAWN cases are identified by the systematic review of ED medical records in participating hospitals. The unit of analysis is any ED visit involving recent drug use. DAWN captures both ED visits that are directly caused by drugs and those in which drugs are a contributing factor but not the direct cause of the ED visit. The reason a patient used a drug is not part of the criteria for considering a visit to be drug related. Therefore, all types of drug-related events are included: drug misuse or abuse, accidental drug ingestion, drug-related suicide attempts, malicious drug poisonings, and adverse reactions. DAWN does not report current medications (i.e., medications and pharmaceuticals taken regularly by the patient as prescribed or indicated) that are unrelated to the ED visit. The DAWN public-use dataset provides information for all types of drugs, including illegal drugs, prescription drugs, over-the-counter medications, dietary supplements, anesthetic gases, substances that have psychoactive effects when inhaled, alcohol when used in combination with other drugs (all ages), and alcohol alone (only for patients aged 20 or younger). Public-use dataset variables describe and categorize up to 16 drugs contributing to the ED visit, including toxicology confirmation and route of administration. Administrative variables specify the type of case, case disposition, categorized episode time of day, and quarter of year. Metropolitan area is included for represented metropolitan areas. Created variables include the number of unique drugs reported and case-level indicators for alcohol, non-alcohol illicit, any pharmaceutical, non-medical use of pharmaceuticals, and all misuse and abuse. Demographic items include age category, sex, and race/ethnicity. Complex sample design and weighting variables are included to calculate various estimates of drug-related ED visits for the Nation as a whole, as well as for specific metropolitan areas, from the ED visits classified as DAWN cases in the selected hospitals. Cf.: http://dx.doi.org/10.3886/ICPSR32861.v1 alcohol icpsr demographic characteristics icpsr detoxification icpsr drug overdose icpsr drug use icpsr emergency departments icpsr nonprescription drugs icpsr over-the-counter drugs icpsr substance abuse icpsr suicide icpsr NAHDAP I. National Addiction and HIV Data Archive Program SAMHDA VIII. Drug Abuse Warning Network (DAWN) ICPSR IX. Health Care and Health Facilities United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies Inter-university Consortium for Political and Social Research. ICPSR (Series) 32861 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR32861.v1 nmm 22 4500 ICPSR23782 MiAaI m f a u cr mn mmmmuuuu 130521s2008 miu f a eng d (MiAaI)ICPSR23782 MiAaI MiAaI National Survey on Drug Use and Health, 2007 [electronic resource] United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies 2013-01-04 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 2008 ICPSR 23782 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) primarily measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2007 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention-related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey. Background information includes gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition. Cf.: http://dx.doi.org/10.3886/ICPSR23782.v3 mental health services icpsr methamphetamine icpsr pregnancy icpsr prescription drugs icpsr sedatives icpsr smoking icpsr stimulants icpsr substance abuse icpsr substance abuse treatment icpsr tobacco use icpsr tranquilizers icpsr youths icpsr barbiturates icpsr cocaine icpsr controlled drugs icpsr addiction icpsr alcohol icpsr alcohol abuse icpsr alcohol consumption icpsr amphetamines icpsr crack cocaine icpsr demographic characteristics icpsr depression (psychology) icpsr drinking behavior icpsr drug abuse icpsr drug dependence icpsr drug treatment icpsr drug use icpsr drugs icpsr employment icpsr hallucinogens icpsr health care icpsr heroin icpsr households icpsr income icpsr inhalants icpsr marijuana icpsr mental health icpsr SAMHDA I. National Survey on Drug Use and Health (NSDUH) NACJD XI. Drugs, Alcohol, and Crime RCMD V. Health and Well-Being RCMD I. Crime ICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice System DSDR III. Health NAHDAP I. National Addiction and HIV Data Archive Program United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies Inter-university Consortium for Political and Social Research. ICPSR (Series) 23782 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR23782.v3 nmm 22 4500 ICPSR33221 MiAaI m f a u cr mn mmmmuuuu 130521s2012 miu f a eng d (MiAaI)ICPSR33221 MiAaI MiAaI Drug Abuse Warning Network (DAWN), 2006 [electronic resource] United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies. 2012-06-12 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 2012 ICPSR 33221 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. The Drug Abuse Warning Network (DAWN) is a nationally representative public health surveillance system that has monitored drug related emergency department (ED) visits to hospitals since the early 1970s. First administered by the Drug Enforcement Administration (DEA) and the National Institute on Drug Abuse (NIDA), the responsibility for DAWN now rests with SAMHSA’s Center for Behavioral Health Statistics and Quality (CBHSQ). Over the years, the exact survey methodology has been adjusted to improve the quality, reliability, and generalizability of the information produced by DAWN. The current approach was first fully implemented in the 2004 data collection year. DAWN relies on a longitudinal probability sample of hospitals located throughout the United States. To be eligible for selection into the DAWN sample, a hospital must be a non-Federal, short-stay, general surgical and medical hospital located in the United States, with at least one 24-hour ED. DAWN cases are identified by the systematic review of ED medical records in participating hospitals. The unit of analysis is any ED visit involving recent drug use. DAWN captures both ED visits that are directly caused by drugs and those in which drugs are a contributing factor but not the direct cause of the ED visit. The reason a patient used a drug is not part of the criteria for considering a visit to be drug related. Therefore, all types of drug-related events are included: drug misuse or abuse, accidental drug ingestion, drug-related suicide attempts, malicious drug poisonings, and adverse reactions. DAWN does not report current medications (i.e., medications and pharmaceuticals taken regularly by the patient as prescribed or indicated) that are unrelated to the ED visit. The DAWN public-use dataset provides information for all types of drugs, including illegal drugs, prescription drugs, over-the-counter medications, dietary supplements, anesthetic gases, substances that have psychoactive effects when inhaled, alcohol when used in combination with other drugs (all ages), and alcohol alone (only for patients aged 20 or younger). Public-use dataset variables describe and categorize up to 16 drugs contributing to the ED visit, including toxicology confirmation and route of administration. Administrative variables specify the type of case, case disposition, categorized episode time of day, and quarter of year. Metropolitan area is included for represented metropolitan areas. Created variables include the number of unique drugs reported and case-level indicators for alcohol, non-alcohol illicit, any pharmaceutical, non-medical use of pharmaceuticals, and all misuse and abuse. Demographic items include age category, sex, and race/ethnicity. Complex sample design and weighting variables are included to calculate various estimates of drug-related ED visits for the Nation as a whole, as well as for specific metropolitan areas, from the ED visits classified as DAWN cases in the selected hospitals. Cf.: http://dx.doi.org/10.3886/ICPSR33221.v1 alcohol icpsr demographic characteristics icpsr detoxification icpsr drug overdose icpsr drug use icpsr emergency departments icpsr nonprescription drugs icpsr over-the-counter drugs icpsr substance abuse icpsr suicide icpsr ICPSR IX. Health Care and Health Facilities NAHDAP I. National Addiction and HIV Data Archive Program SAMHDA VIII. Drug Abuse Warning Network (DAWN) United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies. Inter-university Consortium for Political and Social Research. ICPSR (Series) 33221 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR33221.v1 nmm 22 4500 ICPSR21240 MiAaI m f a u cr mn mmmmuuuu 130521s2007 miu f a eng d (MiAaI)ICPSR21240 MiAaI MiAaI National Survey on Drug Use and Health, 2006 [electronic resource] United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies 2013-01-07 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 2007 ICPSR 21240 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) primarily measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2006 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention-related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey. Background information includes gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition. Cf.: http://dx.doi.org/10.3886/ICPSR21240.v5 drinking behavior icpsr drug abuse icpsr drug dependence icpsr drug treatment icpsr drug use icpsr drugs icpsr employment icpsr hallucinogens icpsr health care icpsr heroin icpsr households icpsr income icpsr inhalants icpsr marijuana icpsr mental health icpsr mental health services icpsr methamphetamine icpsr pregnancy icpsr prescription drugs icpsr sedatives icpsr smoking icpsr stimulants icpsr substance abuse icpsr substance abuse treatment icpsr tobacco use icpsr tranquilizers icpsr youths icpsr addiction icpsr alcohol icpsr alcohol abuse icpsr alcohol consumption icpsr amphetamines icpsr barbiturates icpsr cocaine icpsr controlled drugs icpsr crack cocaine icpsr demographic characteristics icpsr depression (psychology) icpsr SAMHDA I. National Survey on Drug Use and Health (NSDUH) NAHDAP I. National Addiction and HIV Data Archive Program ICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice System RCMD V. Health and Well-Being RCMD I. Crime NACJD XI. Drugs, Alcohol, and Crime United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies Inter-university Consortium for Political and Social Research. ICPSR (Series) 21240 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR21240.v5 nmm 22 4500 ICPSR33042 MiAaI m f a u cr mn mmmmuuuu 130521s2012 miu f a eng d (MiAaI)ICPSR33042 MiAaI MiAaI Drug Abuse Warning Network (DAWN), 2005 [electronic resource] United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies. 2012-09-11 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 2012 ICPSR 33042 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. The Drug Abuse Warning Network (DAWN) is a nationally representative public health surveillance system that has monitored drug related emergency department (ED) visits to hospitals since the early 1970s. First administered by the Drug Enforcement Administration (DEA) and the National Institute on Drug Abuse (NIDA), the responsibility for DAWN now rests with SAMHSA’s Center for Behavioral Health Statistics and Quality (CBHSQ). Over the years, the exact survey methodology has been adjusted to improve the quality, reliability, and generalizability of the information produced by DAWN. The current approach was first fully implemented in the 2004 data collection year. DAWN relies on a longitudinal probability sample of hospitals located throughout the United States. To be eligible for selection into the DAWN sample, a hospital must be a non-Federal, short-stay, general surgical and medical hospital located in the United States, with at least one 24-hour ED. DAWN cases are identified by the systematic review of ED medical records in participating hospitals. The unit of analysis is any ED visit involving recent drug use. DAWN captures both ED visits that are directly caused by drugs and those in which drugs are a contributing factor but not the direct cause of the ED visit. The reason a patient used a drug is not part of the criteria for considering a visit to be drug related. Therefore, all types of drug-related events are included: drug misuse or abuse, accidental drug ingestion, drug-related suicide attempts, malicious drug poisonings, and adverse reactions. DAWN does not report current medications (i.e., medications and pharmaceuticals taken regularly by the patient as prescribed or indicated) that are unrelated to the ED visit. The DAWN public-use dataset provides information for all types of drugs, including illegal drugs, prescription drugs, over-the-counter medications, dietary supplements, anesthetic gases, substances that have psychoactive effects when inhaled, alcohol when used in combination with other drugs (all ages), and alcohol alone (only for patients aged 20 or younger). Public-use dataset variables describe and categorize up to 16 drugs contributing to the ED visit, including toxicology confirmation and route of administration. Administrative variables specify the type of case, case disposition, categorized episode time of day, and quarter of year. Metropolitan area is included for represented metropolitan areas. Created variables include the number of unique drugs reported and case-level indicators for alcohol, non-alcohol illicit, any pharmaceutical, non-medical use of pharmaceuticals, and all misuse and abuse. Demographic items include age category, sex, and race/ethnicity. Complex sample design and weighting variables are included to calculate various estimates of drug-related ED visits for the Nation as a whole, as well as for specific metropolitan areas, from the ED visits classified as DAWN cases in the selected hospitals. Cf.: http://dx.doi.org/10.3886/ICPSR33042.v1 alcohol icpsr demographic characteristics icpsr detoxification icpsr drug overdose icpsr drug use icpsr emergency departments icpsr nonprescription drugs icpsr over-the-counter drugs icpsr substance abuse icpsr suicide icpsr SAMHDA VIII. Drug Abuse Warning Network (DAWN) ICPSR IX. Health Care and Health Facilities NAHDAP I. National Addiction and HIV Data Archive Program United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies. Inter-university Consortium for Political and Social Research. ICPSR (Series) 33042 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR33042.v1 nmm 22 4500 ICPSR04596 MiAaI m f a u cr mn mmmmuuuu 130521s2006 miu f a eng d (MiAaI)ICPSR04596 MiAaI MiAaI National Survey on Drug Use and Health, 2005 [electronic resource] United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies 2013-01-22 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 2006 ICPSR 4596 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) primarily measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2005 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention-related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey. Background information includes gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition. Cf.: http://dx.doi.org/10.3886/ICPSR04596.v3 substance abuse icpsr substance abuse treatment icpsr tobacco use icpsr tranquilizers icpsr youths icpsr alcohol abuse icpsr alcohol consumption icpsr amphetamines icpsr barbiturates icpsr cocaine icpsr controlled drugs icpsr crack cocaine icpsr addiction icpsr alcohol icpsr demographic characteristics icpsr depression (psychology) icpsr drinking behavior icpsr drug abuse icpsr drug dependence icpsr drug treatment icpsr drug use icpsr drugs icpsr hallucinogens icpsr heroin icpsr households icpsr income icpsr inhalants icpsr marijuana icpsr mental health icpsr mental health services icpsr methamphetamine icpsr prescription drugs icpsr sedatives icpsr smoking icpsr stimulants icpsr NACJD XI. Drugs, Alcohol, and Crime RCMD V. Health and Well-Being ICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice System SAMHDA I. National Survey on Drug Use and Health (NSDUH) NAHDAP I. National Addiction and HIV Data Archive Program RCMD I. Crime FENWAY I. Fenway Archive Project United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies Inter-university Consortium for Political and Social Research. ICPSR (Series) 4596 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR04596.v3 nmm 22 4500 ICPSR33041 MiAaI m f a u cr mn mmmmuuuu 130521s2012 miu f a eng d (MiAaI)ICPSR33041 MiAaI MiAaI Drug Abuse Warning Network (DAWN), 2004 [electronic resource] United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies. 2012-09-11 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 2012 ICPSR 33041 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. The Drug Abuse Warning Network (DAWN) is a nationally representative public health surveillance system that has monitored drug related emergency department (ED) visits to hospitals since the early 1970s. First administered by the Drug Enforcement Administration (DEA) and the National Institute on Drug Abuse (NIDA), the responsibility for DAWN now rests with SAMHSA’s Center for Behavioral Health Statistics and Quality (CBHSQ). Over the years, the exact survey methodology has been adjusted to improve the quality, reliability, and generalizability of the information produced by DAWN. The current approach was first fully implemented in the 2004 data collection year. DAWN relies on a longitudinal probability sample of hospitals located throughout the United States. To be eligible for selection into the DAWN sample, a hospital must be a non-Federal, short-stay, general surgical and medical hospital located in the United States, with at least one 24-hour ED. DAWN cases are identified by the systematic review of ED medical records in participating hospitals. The unit of analysis is any ED visit involving recent drug use. DAWN captures both ED visits that are directly caused by drugs and those in which drugs are a contributing factor but not the direct cause of the ED visit. The reason a patient used a drug is not part of the criteria for considering a visit to be drug related. Therefore, all types of drug-related events are included: drug misuse or abuse, accidental drug ingestion, drug-related suicide attempts, malicious drug poisonings, and adverse reactions. DAWN does not report current medications (i.e., medications and pharmaceuticals taken regularly by the patient as prescribed or indicated) that are unrelated to the ED visit. The DAWN public-use dataset provides information for all types of drugs, including illegal drugs, prescription drugs, over-the-counter medications, dietary supplements, anesthetic gases, substances that have psychoactive effects when inhaled, alcohol when used in combination with other drugs (all ages), and alcohol alone (only for patients aged 20 or younger). Public-use dataset variables describe and categorize up to 16 drugs contributing to the ED visit, including toxicology confirmation and route of administration. Administrative variables specify the type of case, case disposition, categorized episode time of day, and quarter of year. Metropolitan area is included for represented metropolitan areas. Created variables include the number of unique drugs reported and case-level indicators for alcohol, non-alcohol illicit, any pharmaceutical, non-medical use of pharmaceuticals, and all misuse and abuse. Demographic items include age category, sex, and race/ethnicity. Complex sample design and weighting variables are included to calculate various estimates of drug-related ED visits for the Nation as a whole, as well as for specific metropolitan areas, from the ED visits classified as DAWN cases in the selected hospitals. Cf.: http://dx.doi.org/10.3886/ICPSR33041.v1 over-the-counter drugs icpsr substance abuse icpsr suicide icpsr alcohol icpsr demographic characteristics icpsr detoxification icpsr drug overdose icpsr drug use icpsr emergency departments icpsr nonprescription drugs icpsr ICPSR IX. Health Care and Health Facilities SAMHDA VIII. Drug Abuse Warning Network (DAWN) NAHDAP I. National Addiction and HIV Data Archive Program United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies. Inter-university Consortium for Political and Social Research. ICPSR (Series) 33041 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR33041.v1 nmm 22 4500 ICPSR04373 MiAaI m f a u cr mn mmmmuuuu 130521s2006 miu f a eng d (MiAaI)ICPSR04373 MiAaI MiAaI National Survey on Drug Use and Health, 2004 [electronic resource] United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies 2013-02-06 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 2006 ICPSR 4373 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2004 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention-related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey and retained through the 2003 survey. Background information includes gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition. Cf.: http://dx.doi.org/10.3886/ICPSR04373.v2 addiction icpsr alcohol icpsr alcohol abuse icpsr alcohol consumption icpsr amphetamines icpsr barbiturates icpsr cocaine icpsr controlled drugs icpsr crack cocaine icpsr demographic characteristics icpsr depression (psychology) icpsr drinking behavior icpsr drug abuse icpsr drug dependence icpsr drug treatment icpsr drug use icpsr drugs icpsr hallucinogens icpsr heroin icpsr households icpsr income icpsr inhalants icpsr marijuana icpsr mental health icpsr mental health services icpsr methamphetamine icpsr prescription drugs icpsr sedatives icpsr smoking icpsr stimulants icpsr substance abuse icpsr substance abuse treatment icpsr tranquilizers icpsr youths icpsr tobacco use icpsr ICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice System RCMD I. Crime NACJD XI. Drugs, Alcohol, and Crime NAHDAP I. National Addiction and HIV Data Archive Program SAMHDA I. National Survey on Drug Use and Health (NSDUH) RCMD V. Health and Well-Being United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies Inter-university Consortium for Political and Social Research. ICPSR (Series) 4373 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR04373.v2 nmm 22 4500 ICPSR02778 MiAaI m f a u cr mn mmmmuuuu 130521s2002 miu f a eng d (MiAaI)ICPSR02778 MiAaI MiAaI Gambling Impact and Behavior Study, 1997-1999 [electronic resource] [United States] National Gambling Impact Study Commission 2007-08-28 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 2002 ICPSR 2778 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. The Gambling Impact and Behavior Study investigates the gambling behavior and attitudes of adults and youth in America, and also estimates the effects of gambling facilities on a variety of local economic and social indicators. Respondents were randomly selected by a national random-digit dial (RDD) through a stratified design by state lottery status and distances to major casino. The study includes three independent, unlinkable data files. The adult and youth questionnaire (Parts 1 and 2) covered areas such as demographic information, geographic region, gambling behavior and attitudes, motivations for gambling, gambling history, a problem-gambling diagnostic assessment, gambling treatment experience, family/marital status and issues, income and financial information, criminal activity, mental and general health, and substance use. Areas of substance abuse examined were the use of alcohol, marijuana, hashish, cocaine, crack, methamphetamine, stimulants, tranquilizers, amphetamines, and speed. The Community Database (Part 3) included the following: geographic locators (latitude, longitude), availability of gaming facilities, gaming spending estimates, employment patterns by industry, unemployment, bankruptcy, personal income, private and public earnings, government expenditures, income maintenance/AFDC, and vital statistics. Cf.: http://dx.doi.org/10.3886/ICPSR02778.v2 attitudes icpsr casinos icpsr demographic characteristics icpsr economic indicators icpsr gambling icpsr human behavior icpsr social indicators icpsr ICPSR XVI.A. Social Indicators, United States SAMHDA XVII. Gambling Impact and Behavior Study National Gambling Impact Study Commission Inter-university Consortium for Political and Social Research. ICPSR (Series) 2778 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR02778.v2 nmm 22 4500 ICPSR02258 MiAaI m f a u cr mn mmmmuuuu 130521s2000 miu f a eng d (MiAaI)ICPSR02258 MiAaI MiAaI Drug Abuse Treatment Outcome Study (DATOS), 1991-1994 [electronic resource] [United States] United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse 2010-02-16 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 2000 ICPSR 2258 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. Drug-Abuse Treatment Outcomes Study (DATOS) is a prospective study designed to determine the outcomes of adult drug abuse treatment delivered in typical, stable, community-based programs and to provide comprehensive information on continuing and new questions about the effectiveness of drug abuse treatment for adults currently available in a variety of publicly funded and private programs. The study examined the role of treatment outcomes and program type, client characteristics (including dependence, treatment history, and physical and mental health comorbidities), treatment received (e.g., length and intensity of services provided), therapeutic approaches, provision of aftercare, and research on the components of effective treatment, including factors that engage and retain clients in programs. Four types of programs were included: outpatient methadone (OPM), short-term inpatient (STI), long-term residential (LTR), and outpatient drug-free (ODF). Respondents were sampled from among adults admitted to drug abuse treatment programs in 11 representative U.S. cities during 1991-1993. Clients entering treatment completed two comprehensive intake interviews (Intake 1 and Intake 2), approximately one week apart. This information is provided in Parts 1 and 2 of the data collection. These interviews were designed to obtain baseline data on drug use and other behaviors, as well as information on background and demographic characteristics, patterns of dependence, living situation and child custody status, education and training, income and expenditures, and HIV risk behaviors, along with assessments of dependence, mental health, physical health, and social functioning. Data on criminal justice status and criminal behavior are reported in Part 5, Illegal Activities Data, and are drawn from the Intake 1 interview. Data reflecting during-treatment progress, including service delivery and client satisfaction, were collected in the one-, three-, and six-month in-treatment interviews (Parts 3, 4, and 8). The 12-Month Post-Treatment Follow-Up Interview (Part 6) replicated many of the intake questions and focused on key behaviors in the year following treatment. Part 7 includes variables for time in treatment and interview availability indicators. The 12-Month Follow-Up Urine Result data (Part 9) provide the results from urine sample tests that were given to a sample of subjects at the time of the 12-Month Follow-Up Interview. Urine specimens were tested for eight categories of drugs (amphetamines, barbiturates, benzodiazepines, cannabinoids, cocaine metabolite, methaqualone, opiates, and phencyclidine). The drugs covered in the study were alcohol, tobacco, marijuana (hashish, THC), hallucinogens or psychedelics such as LSD, mescaline, and PCP, cocaine (including crack), heroin, narcotics or opiates such as morphine, codeine, Demerol, Dilaudid, and Talwin, downers or depressants such as sedatives, barbiturates, and tranquilizers, amphetamines or other stimulants such as speed or diet pills, and other drugs. Part 10 contains data for 1393 clients who were interviewed 5 years post treatment. This part contains many of the same types of questions asked during previous interviews. Cf.: http://dx.doi.org/10.3886/ICPSR02258.v5 AIDS icpsr criminal histories icpsr demographic characteristics icpsr drug abuse icpsr drug treatment icpsr HIV icpsr mental health icpsr physical condition icpsr treatment outcome icpsr treatment programs icpsr NAHDAP I. National Addiction and HIV Data Archive Program SAMHDA VII. Drug Abuse Treatment Outcome Study (DATOS) ICPSR XVI.A. Social Indicators, United States United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse Inter-university Consortium for Political and Social Research. ICPSR (Series) 2258 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR02258.v5 nmm 22 4500 ICPSR02934 MiAaI m f a u cr mn mmmmuuuu 130521s2000 miu f a eng d (MiAaI)ICPSR02934 MiAaI MiAaI National Household Survey on Drug Abuse, 1998 [electronic resource] United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies 2013-05-06 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 2000 ICPSR 2934 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. The National Household Survey on Drug Abuse (NHSDA) series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions include age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including psychotherapeutics. Respondents were also asked about personal and family income sources and amounts, substance abuse treatment history, illegal activities, problems resulting from the use of drugs, need for treatment for drug or alcohol use, criminal record, and needle-sharing. Questions on mental health and access to care, which were introduced in the 1994-B questionnaire (see NATIONAL HOUSEHOLD SURVEY ON DRUG ABUSE, 1994 [ICPSR 6949]), were retained in this administration of the survey. Also retained was the section on risk/availability of drugs that was reintroduced in 1996, and sections on driving behavior and personal behavior were added (see NATIONAL HOUSEHOLD SURVEY ON DRUG ABUSE, 1996 [ICPSR 2391]). The 1997 questionnaire (NATIONAL HOUSEHOLD SURVEY ON DRUG ABUSE, 1997 [ICPSR 2755]) introduced new items that the 1998 NHSDA continued on cigar smoking, people who were present when respondents used marijuana or cocaine for the first time (if applicable), reasons for using these two drugs the first time, reasons for using these two drugs in the past year, reasons for discontinuing use of these two drugs (for lifetime but not past-year users), and reasons respondents never used these two drugs. Both the 1997 and 1998 NHSDAs had a series of questions that were asked only of respondents aged 12 to 17. These items covered a variety of topics that may be associated with substance use and related behaviors, such as exposure to substance abuse prevention and education programs, gang involvement, relationship with parents, and substance use by friends. Demographic data include gender, race, age, ethnicity, marital status, educational level, job status, income level, veteran status, and current household composition. Cf.: http://dx.doi.org/10.3886/ICPSR02934.v4 alcohol icpsr alcohol abuse icpsr alcohol consumption icpsr amphetamines icpsr barbiturates icpsr cocaine icpsr demographic characteristics icpsr drug abuse icpsr drug use icpsr drugs icpsr hallucinogens icpsr health care icpsr health insurance icpsr heroin icpsr households icpsr inhalants icpsr marijuana icpsr mental health icpsr mental health services icpsr methamphetamine icpsr prescription drugs icpsr sedatives icpsr smoking icpsr stimulants icpsr substance abuse icpsr substance abuse treatment icpsr tobacco use icpsr tranquilizers icpsr youths icpsr NAHDAP I. National Addiction and HIV Data Archive Program RCMD V. Health and Well-Being RCMD I. Crime ICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice System SAMHDA I. National Survey on Drug Use and Health (NSDUH) NACJD XI. Drugs, Alcohol, and Crime United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies Inter-university Consortium for Political and Social Research. ICPSR (Series) 2934 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR02934.v4 nmm 22 4500 ICPSR02755 MiAaI m f a u cr mn mmmmuuuu 130521s1999 miu f a eng d (MiAaI)ICPSR02755 MiAaI MiAaI National Household Survey on Drug Abuse, 1997 [electronic resource] United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies 2013-05-06 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 1999 ICPSR 2755 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. This series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions include age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including psychotherapeutics. Respondents were also asked about substance abuse treatment history, illegal activities, problems resulting from the use of drugs, personal and family income sources and amounts, need for treatment for drug or alcohol use, criminal record, and needle-sharing. Questions on mental health and access to care, which were introduced in the 1994-B questionnaire (see NATIONAL HOUSEHOLD SURVEY ON DRUG ABUSE, 1994 [ICPSR 6949]), were retained in this administration of the survey. In 1996, the section on risk/availability of drugs was reintroduced, and sections on driving behavior and personal behavior were added (see NATIONAL HOUSEHOLD SURVEY ON DRUG ABUSE, 1996 [ICPSR 2391]). The 1997 questionnaire continued the risk/availability section along with new items about the use of cigars, people present when respondents used marijuana or cocaine for the first time (if applicable), reasons for using these two drugs the first time, reasons for using these two drugs in the past year, reasons for discontinuing use of these two drugs (for lifetime but not past-year users), and reasons respondents never used these two drugs. In addition, a new series of questions asked only of respondents aged 12 to 17 was introduced. These items covered a variety of topics that may be associated with substance use and related behaviors, such as exposure to substance abuse prevention and education programs, gang involvement, relationship with parents, and substance use by friends. Demographic data include gender, race, age, ethnicity, marital status, educational level, job status, income level, veteran status, and current household composition. Cf.: http://dx.doi.org/10.3886/ICPSR02755.v3 demographic characteristics icpsr alcohol abuse icpsr alcohol consumption icpsr amphetamines icpsr barbiturates icpsr cocaine icpsr drug abuse icpsr drug use icpsr drugs icpsr hallucinogens icpsr marijuana icpsr mental health icpsr mental health services icpsr methamphetamine icpsr offenses icpsr prescriptions drugs icpsr sedatives icpsr smoking icpsr stimulants icpsr substance abuse icpsr substance abuse treatment icpsr tobacco use icpsr tranquilizers icpsr youths icpsr health care icpsr health insurance icpsr heroin icpsr households icpsr inhalants icpsr ICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice System RCMD V. Health and Well-Being NAHDAP I. National Addiction and HIV Data Archive Program RCMD I. Crime SAMHDA I. National Survey on Drug Use and Health (NSDUH) NACJD XI. Drugs, Alcohol, and Crime United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies Inter-university Consortium for Political and Social Research. ICPSR (Series) 2755 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR02755.v3 nmm 22 4500 ICPSR02834 MiAaI m f a u cr mn mmmmuuuu 130521s1999 miu f a eng d (MiAaI)ICPSR02834 MiAaI MiAaI Drug Abuse Warning Network (DAWN), 1997 [electronic resource] [United States] United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies 2008-03-04 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 1999 ICPSR 2834 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. The Drug Abuse Warning Network (DAWN) survey is designed to capture data on emergency department (ED) episodes that are induced by or related to the use of an illicit, prescription, or over-the-counter drug. For purposes of this collection, a drug "episode" is an ED visit that was induced by or related to the use of an illegal drug or the nonmedical use of a legal drug for patients aged six years and older. A drug "mention" refers to a substance that was mentioned during a drug-related ED episode. Because up to four drugs can be reported for each drug abuse episode, there are more mentions than episodes in the data. Individual persons may also be included more than once in the data. Within each facility participating in DAWN, a designated reporter, usually a member of the emergency department or medical records staff, was responsible for identifying drug-related episodes and recording and submitting data on each case. An episode report was submitted for each patient visiting a DAWN emergency department whose presenting problem(s) was/were related to their own drug use. DAWN produces estimates of drug-related emergency department visits for 50 specific drugs, drug categories, or combinations of drugs, including the following: acetaminophen, alcohol in combination with other drugs, alprazolam, amitriptyline, amphetamines, aspirin, cocaine, codeine, diazepam, diphenhydramine, fluoxetine, heroin/morphine, inhalants/solvents/aerosols, LSD, lorazepam, marijuana/hashish, methadone, methamphetamine, and PCP/PCP in combination with other drugs. The use of alcohol alone is not reported. The route of administration and form of drug used (e.g., powder, tablet, liquid) are included for each drug. Data collected for DAWN also include drug use motive and total drug mentions in the episode, as well as race, age, patient disposition, reason for ED visit, and day of the week, quarter, and year of episode. Cf.: http://dx.doi.org/10.3886/ICPSR02834.v2 emergency services icpsr health behavior icpsr hospitalization icpsr demographic characteristics icpsr substance abuse icpsr drug abuse icpsr drug dependence icpsr drug overdose icpsr drug use icpsr emergencies icpsr NAHDAP I. National Addiction and HIV Data Archive Program ICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice System ICPSR XVI.A. Social Indicators, United States NACJD XI. Drugs, Alcohol, and Crime SAMHDA VIII. Drug Abuse Warning Network (DAWN) United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies Inter-university Consortium for Political and Social Research. ICPSR (Series) 2834 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR02834.v2 nmm 22 4500 ICPSR02391 MiAaI m f a u cr mn mmmmuuuu 130521s1998 miu f a eng d (MiAaI)ICPSR02391 MiAaI MiAaI National Household Survey on Drug Abuse, 1996 [electronic resource] United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies 2013-05-06 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 1998 ICPSR 2391 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. This series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions include age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including psychotherapeutics. Respondents were also asked about substance abuse treatment history, illegal activities, problems resulting from the use of drugs, personal and family income sources and amounts, need for treatment for drug or alcohol use, criminal record, and needle-sharing. Questions on mental health and access to care, which were introduced in the 1994-B questionnaire (see NATIONAL HOUSEHOLD SURVEY ON DRUG ABUSE, 1994 [ICPSR 6949]), were retained in this administration of the survey. In 1996, the section on risk/availability of drugs was reintroduced, and sections on driving behavior and personal behavior were added. Demographic data include gender, race, age, ethnicity, marital status, educational level, job status, income level, veteran status, and current household composition. Cf.: http://dx.doi.org/10.3886/ICPSR02391.v2 alcohol abuse icpsr alcohol consumption icpsr amphetamines icpsr barbiturates icpsr cocaine icpsr crime icpsr demographic characteristics icpsr drug abuse icpsr drug use icpsr drugs icpsr hallucinogens icpsr health care icpsr health insurance icpsr heroin icpsr HIV icpsr households icpsr inhalants icpsr marijuana icpsr mental health icpsr mental health services icpsr methamphetamine icpsr prescription drugs icpsr smoking icpsr stimulants icpsr substance abuse icpsr substance abuse treatment icpsr tranquilizers icpsr youths icpsr FENWAY VI. Studies That Include Heterosexual Populations RCMD V. Health and Well-Being SAMHDA I. National Survey on Drug Use and Health (NSDUH) RCMD I. Crime ICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice System NAHDAP I. National Addiction and HIV Data Archive Program NACJD XI. Drugs, Alcohol, and Crime United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies Inter-university Consortium for Political and Social Research. ICPSR (Series) 2391 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR02391.v2 nmm 22 4500 ICPSR02691 MiAaI m f a u cr mn mmmmuuuu 130521s2000 miu f a eng d (MiAaI)ICPSR02691 MiAaI MiAaI Services Research Outcomes Study, 1995-1996 [electronic resource] [United States] United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies 2008-10-29 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 2000 ICPSR 2691 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. The Services Research Outcomes Study (SROS) sought to answer questions about drug treatment efficacy and to describe client characteristics. The study was designed to provide (1) a 1990 cohort of clients to use as baseline for possible changes in treatment outcomes following increased funding to the national treatment system in the 1990s, (2) a before-to-after comparison to measure outcomes of treatment provided in 1990, (3) a follow-up of drug treatment clients five years after treatment to assess the level of sustained improvements in abstinence, and (4) a first look at multiple treatment episodes before and after treatment in a 1990 population. Part 1 is the Facility Director Interviews and covered topics such as facility staff and organization, revenue and charges, staff hours and compensation, costs, and program characteristics. Part 2 is the Client Records Abstractions Data, which examined the client records of 2,222 individuals discharged during 1989-1990. Information was abstracted on demographic characteristics of clients, criminal justice involvement, medical conditions, drug history including intravenous drug use, urine test results, drug treatment history, treatment services, and discharge and billing information. Part 3 consists of the Client Follow-Up Interviews, and was conducted during 1995 and 1996. This part covered the clients' entire life span, with special attention to their behavior and circumstances during the five years before entry to the index (SROS) treatment in 1989-1990 and after leaving that treatment until the time of the interview. Additional questions were asked on patterns of alcohol and drug consumption, criminal activity, employment, health, social support, and other behavior relevant to treatment goals. Drugs included cocaine, crack, heroin, nontreatment methadone, other opiates/synthetics, barbiturates, benzodiazapine, other sedatives/hypnotics, methamphetamines, other amphetamines, marijuana/hash/THC, PCP/LSD, other hallucinogens, inhalants, over-the-counter medications, and alcohol. Cf.: http://dx.doi.org/10.3886/ICPSR02691.v1 alcohol abuse icpsr treatment facilities icpsr physical health icpsr treatment outcomes icpsr treatment programs icpsr urinalysis icpsr criminal histories icpsr demographic characteristics icpsr drug testing icpsr drug treatment icpsr drug use icpsr employment icpsr mental health icpsr ICPSR XVI.A. Social Indicators, United States NAHDAP I. National Addiction and HIV Data Archive Program SAMHDA X. Services Research Outcomes Study United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies Inter-university Consortium for Political and Social Research. ICPSR (Series) 2691 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR02691.v1 nmm 22 4500 ICPSR03154 MiAaI m f a u cr mn mmmmuuuu 130521s2001 miu f a eng d (MiAaI)ICPSR03154 MiAaI MiAaI Health Behavior in School-Aged Children, 1995-1996 [electronic resource] [United States] World Health Organization 2008-04-23 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 2001 ICPSR 3154 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. Since 1982, the World Health Organization (WHO) Regional Office for Europe has sponsored a cross-national, school-based study of health-related attitudes and behaviors of young people. These studies, generally known as Health Behavior in School-Aged Children (HBSC), are based on nationally independent surveys of school-aged children in as many as 30 participating countries. The HBSC studies were conducted every four years since the 1985-1986 school year. The United States was one of three countries chosen to implement the survey out of cycle. The data available here are the results of the United States study from the 1995-1996 school year. The study results can be used as stand-alone data, or to compare to the other countries involved in the international HBSC. The HBSC study has two main objectives. The first objective is to monitor health-risk behaviors and attitudes in youth over time to provide background and identify targets for health promotion initiatives. The second objective is to provide researchers with relevant information to understand and explain the development of health attitudes and behaviors through early adolescence. The study contains variables dealing with many types of drugs such as tobacco, alcohol, marijuana, cocaine, inhalants, hallucinogens, and over-the-counter medications. The study also examines a person's health and health behaviors such as eating habits, depression, injuries, anti-social behavior including questions concerning bullying, fighting, using weapons, and how one deals with anger. There are also questions concerning problems with attention span at school and opinions about school itself. Cf.: http://dx.doi.org/10.3886/ICPSR03154.v3 adolescents icpsr alcohol icpsr demographic characteristics icpsr drug use icpsr eating habits icpsr educational environment icpsr family life icpsr health behavior icpsr injuries icpsr mental health icpsr school violence icpsr schools icpsr tobacco use icpsr nutrition icpsr risk icpsr school age children icpsr SAMHDA XIV. Health Behavior in School-Aged Children ICPSR XVII.C.1. Social Institutions and Behavior, Socialization, Students, and Youth, United States NAHDAP I. National Addiction and HIV Data Archive Program RCMD V. Health and Well-Being World Health Organization Inter-university Consortium for Political and Social Research. ICPSR (Series) 3154 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR03154.v3 nmm 22 4500 ICPSR06950 MiAaI m f a u cr mn mmmmuuuu 130521s1997 miu f a eng d (MiAaI)ICPSR06950 MiAaI MiAaI National Household Survey on Drug Abuse, 1995 [electronic resource] United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies 2013-05-06 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 1997 ICPSR 6950 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. This series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions include age at first use as well as lifetime, annual, and past-month usage for the following drug classes: cannabis, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, anabolic steroids, nonmedical use of prescription drugs including psychotherapeutics, and polysubstance use. Respondents were also asked about substance abuse treatment history, illegal activities, problems resulting from use of drugs, perceptions of the risks involved, personal and family income sources and amounts, need for treatment for drug or alcohol use, criminal record, and needle-sharing. Questions on mental health and access to care, which were introduced in the 1994-B questionnaire (see NATIONAL HOUSEHOLD SURVEY ON DRUG ABUSE, 1994 [ICPSR 6949]), were retained in this administration of the survey. Demographic data include gender, race, age, ethnicity, marital status, motor vehicle use, educational level, job status, income level, veteran status, and past and current household composition. Cf.: http://dx.doi.org/10.3886/ICPSR06950.v2 smoking icpsr offenses icpsr health insurance icpsr heroin icpsr households icpsr patients icpsr prescriptions drugs icpsr inhalants icpsr marijuana icpsr mental health icpsr stimulants icpsr substance abuse icpsr substance abuse treatment icpsr tobacco use icpsr tranquilizers icpsr treatment icpsr mental health services icpsr methamphetamine icpsr youths icpsr alcohol abuse icpsr alcohol consumption icpsr amphetamines icpsr barbiturates icpsr cocaine icpsr demographic characteristics icpsr drug abuse icpsr drug use icpsr drugs icpsr hallucinogens icpsr health care icpsr sedatives icpsr RCMD V. Health and Well-Being NACJD XI. Drugs, Alcohol, and Crime SAMHDA I. National Survey on Drug Use and Health (NSDUH) RCMD I. Crime ICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice System NAHDAP I. National Addiction and HIV Data Archive Program United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies Inter-university Consortium for Political and Social Research. ICPSR (Series) 6950 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR06950.v2 nmm 22 4500 ICPSR06949 MiAaI m f a u cr mn mmmmuuuu 130521s1997 miu f a eng d (MiAaI)ICPSR06949 MiAaI MiAaI National Household Survey on Drug Abuse, 1994 [electronic resource] United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies 2008-10-28 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 1997 ICPSR 6949 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. This series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions include age at first use as well as lifetime, annual, and past-month usage for the following drug classes: cannabis, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, anabolic steroids, nonmedical use of prescription-type psychotherapeutic drugs, and polysubstance use. Respondents were also asked about substance abuse treatment history, illegal activities, problems resulting from use of drugs, perceptions of the risks involved, and personal and family income sources and amounts. Questions on need for treatment for drug or alcohol use, criminal record, and needle-sharing were also included. A split sample design using two questionnaires was employed with the 1994 NHSDA. The 1994-A questionnaire is comparable to NHSDA questionnaires prior to 1994 and contains all of the core questions from previous NHSDAs. The 1994-B questionnaire, which includes new questions on access to care and mental health, incorporates significant changes from the previous questionnaires and can only be compared to NHSDA surveys in 1995 and beyond. The changes to the questionnaire were undertaken in order to facilitate respondent cooperation, enhance the clarity of questions, improve the accuracy of responses, and increase the reliability of measurements across survey years. In addition, a rural supplementary sample was included in 1994 to obtain substance abuse prevalence estimates for rural areas. Demographic data include gender, race, age, ethnicity, marital status, motor vehicle use, educational level, job status, income level, veteran status, and past and current household composition. Cf.: http://dx.doi.org/10.3886/ICPSR06949.v1 stimulants icpsr substance abuse icpsr tobacco use icpsr tranquilizers icpsr youths icpsr substance abuse treatment icpsr hallucinogens icpsr health insurance icpsr health status icpsr heroin icpsr households icpsr inhalants icpsr marijuana icpsr mental health icpsr mental health services icpsr methamphetamine icpsr offenses icpsr prescriptions drugs icpsr sedatives icpsr smoking icpsr steroids icpsr alcohol abuse icpsr alcohol consumption icpsr amphetamines icpsr barbiturates icpsr cocaine icpsr demographic characteristics icpsr drug abuse icpsr drug use icpsr drugs icpsr RCMD V. Health and Well-Being ICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice System NAHDAP I. National Addiction and HIV Data Archive Program RCMD I. Crime SAMHDA I. National Survey on Drug Use and Health (NSDUH) NACJD XI. Drugs, Alcohol, and Crime United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies Inter-university Consortium for Political and Social Research. ICPSR (Series) 6949 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR06949.v1 nmm 22 4500 ICPSR02756 MiAaI m f a u cr mn mmmmuuuu 130521s1999 miu f a eng d (MiAaI)ICPSR02756 MiAaI MiAaI Drug Abuse Warning Network (DAWN), 1994 [electronic resource] [United States] United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies 2008-03-04 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 1999 ICPSR 2756 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. The Drug Abuse Warning Network (DAWN) survey is designed to capture data on emergency department (ED) episodes that are induced by or related to the use of an illicit, prescription, or over-the-counter drug. For purposes of this collection, a drug "episode" is an ED visit that was induced by or related to the use of an illegal drug or the nonmedical use of a legal drug for patients aged six years and older. A drug "mention" refers to a substance that was mentioned during a drug-related ED episode. Because up to four drugs can be reported for each drug abuse episode, there are more mentions than episodes in the data. Individual persons may also be included more than once in the data. Within each facility participating in DAWN, a designated reporter, usually a member of the emergency department or medical records staff, was responsible for identifying drug-related episodes and recording and submitting data on each case. An episode report was submitted for each patient visiting a DAWN emergency department whose presenting problem(s) was/were related to their own drug use. DAWN produces estimates of drug-related emergency department visits for 50 specific drugs, drug categories, or combinations of drugs, including the following: acetaminophen, alcohol in combination with other drugs, alprazolam, amitriptyline, amphetamines, aspirin, cocaine, codeine, diazepam, diphenhydramine, fluoxetine, heroin/morphine, inhalants/solvents/aerosols, LSD, lorazepam, marijuana/hashish, methadone, methamphetamine, and PCP/PCP in combination with other drugs. The use of alcohol alone is not reported. The route of administration and form of drug used (e.g., powder, tablet, liquid) are included for each drug. Data collected for DAWN also include drug use motive and total drug mentions in the episode, as well as race, age, patient disposition, reason for ED visit, and day of the week, quarter, and year of episode. Cf.: http://dx.doi.org/10.3886/ICPSR02756.v2 demographic characteristics icpsr substance abuse icpsr drug abuse icpsr drug dependence icpsr drug overdose icpsr drug use icpsr emergencies icpsr emergency services icpsr health behavior icpsr hospitalization icpsr ICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice System ICPSR XVI.A. Social Indicators, United States SAMHDA VIII. Drug Abuse Warning Network (DAWN) NACJD XI. Drugs, Alcohol, and Crime NAHDAP I. National Addiction and HIV Data Archive Program United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies Inter-university Consortium for Political and Social Research. ICPSR (Series) 2756 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR02756.v2 nmm 22 4500 ICPSR06852 MiAaI m f a u cr mn mmmmuuuu 130521s1997 miu f a eng d (MiAaI)ICPSR06852 MiAaI MiAaI National Household Survey on Drug Abuse, 1993 [electronic resource] United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies 2013-05-06 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 1997 ICPSR 6852 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. This series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, anabolic steroids, and tobacco among members of United States households aged 12 and older. Data are also provided on treatment for drug use and on illegal activities related to drug use. Questions include age at first use, as well as lifetime, annual, and past-month usage for the following drug classes: cannabis, inhalants, cocaine, hallucinogens, heroin, alcohol, tobacco, and nonmedical use of psychotherapeutics. Respondents were also asked about problems resulting from their use of drugs, alcohol, and tobacco, their perceptions of the risks involved, insurance coverage, and personal and family income sources and amounts. Demographic data include gender, race, ethnicity, educational level, job status, income level, household composition, and population density. Cf.: http://dx.doi.org/10.3886/ICPSR06852.v2 alcohol abuse icpsr alcohol consumption icpsr amphetamines icpsr barbiturates icpsr cocaine icpsr demographic characteristics icpsr drug abuse icpsr drug use icpsr drugs icpsr hallucinogens icpsr heroin icpsr households icpsr inhalants icpsr marijuana icpsr methamphetamine icpsr offenses icpsr substance abuse icpsr substance abuse treatment icpsr prescription drugs icpsr sedatives icpsr smoking icpsr steroid use icpsr stimulants icpsr tobacco use icpsr tranquilizers icpsr youths icpsr RCMD I. Crime SAMHDA I. National Survey on Drug Use and Health (NSDUH) ICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice System NAHDAP I. National Addiction and HIV Data Archive Program NACJD XI. Drugs, Alcohol, and Crime RCMD V. Health and Well-Being United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies Inter-university Consortium for Political and Social Research. ICPSR (Series) 6852 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR06852.v2 nmm 22 4500 ICPSR02835 MiAaI m f a u cr mn mmmmuuuu 130521s2000 miu f a eng d (MiAaI)ICPSR02835 MiAaI MiAaI National Pregnancy and Health Survey [electronic resource] Drug Use Among Women Delivering Live Births, 1992 United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse 2008-07-31 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 2000 ICPSR 2835 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. The primary objective of the National Pregnancy and Health Survey (NPHS) was to produce national annual estimates of the percentages and numbers of mothers of live newborns in the United States who used selected licit and illicit drugs in the 12 months prior to delivery. A further objective was to describe patterns of prenatal substance use among demographic subgroups of women. Information on demographic and socioeconomic characteristics, obstetric history, and drug treatment of women who delivered infants at sampled hospitals was obtained through an interviewer-administered questionnaire, while data on substance use before and during pregnancy were collected through a questionnaire completed by the respondent and concealed from the interviewer. Respondents were asked about use of the following substances: alcohol, amphetamines, analgesics, cocaine, crack cocaine, barbiturates, hallucinogens, hashish, heroin, marijuana, methadone, methamphetamine, sedatives, stimulants, tobacco, and tranquilizers. Additionally, information was collected on the respondent's pregnancy, prenatal care, delivery, previous pregnancies, and background. Additional data were obtained from the mothers' and infants' medical records. Urine specimens collected routinely by the hospital on obstetric admissions were tested for selected drugs. Finally, in a subsample of six hospitals, hair specimens were requested from respondents to evaluate the potential of hair as a source of toxicological data in future studies. Cf.: http://dx.doi.org/10.3886/ICPSR02835.v2 alcohol icpsr amphetamines icpsr cocaine icpsr demographic characteristics icpsr drug testing icpsr drug treatment icpsr drug use icpsr economic indicators icpsr heroin icpsr hospitals icpsr live births icpsr marijuana icpsr methadone icpsr pregnancy icpsr prenatal care icpsr reproductive history icpsr sedatives icpsr tobacco use icpsr tranquilizers icpsr urinalysis icpsr women icpsr AHRQMCC I. Multiple Chronic Conditions NAHDAP I. National Addiction and HIV Data Archive Program SAMHDA XI. National Pregnancy and Health Survey (NPHS) ICPSR XVI.A. Social Indicators, United States United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse Inter-university Consortium for Political and Social Research. ICPSR (Series) 2835 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR02835.v2 nmm 22 4500 ICPSR06887 MiAaI m f a u cr mn mmmmuuuu 130521s1997 miu f a eng d (MiAaI)ICPSR06887 MiAaI MiAaI National Household Survey on Drug Abuse, 1992 [electronic resource] United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies 2013-05-06 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 1997 ICPSR 6887 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. This series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, anabolic steroids, and tobacco among members of United States households aged 12 and older. Data are also provided on treatment for drug use and on illegal activities related to drug use. Questions include age at first use, as well as lifetime, annual, and past-month usage for the following drug classes: cannabis, inhalants, cocaine, hallucinogens, heroin, alcohol, tobacco, and nonmedical use of psychotherapeutics. Respondents were also asked about problems resulting from their use of drugs, alcohol, and tobacco, their perceptions of the risks involved, insurance coverage, and personal and family income sources and amounts. Demographic data include gender, race, ethnicity, educational level, job status, income level, household composition, and population density. Cf.: http://dx.doi.org/10.3886/ICPSR06887.v3 alcohol abuse icpsr alcohol consumption icpsr amphetamines icpsr barbiturates icpsr cocaine icpsr demographic characteristics icpsr drug abuse icpsr drug use icpsr drugs icpsr hallucinogens icpsr heroin icpsr households icpsr inhalants icpsr marijuana icpsr methamphetamine icpsr prescription drugs icpsr sedatives icpsr smoking icpsr steroid use icpsr stimulants icpsr substance abuse icpsr substance abuse treatment icpsr tobacco use icpsr tranquilizers icpsr youths icpsr RCMD V. Health and Well-Being NACJD XI. Drugs, Alcohol, and Crime ICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice System SAMHDA I. National Survey on Drug Use and Health (NSDUH) NAHDAP I. National Addiction and HIV Data Archive Program RCMD I. Crime United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies Inter-university Consortium for Political and Social Research. ICPSR (Series) 6887 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR06887.v3 nmm 22 4500 ICPSR02347 MiAaI m f a u cr mn mmmmuuuu 130521s1998 miu f a eng d (MiAaI)ICPSR02347 MiAaI MiAaI Washington, DC, Metropolitan Area Drug Study (DC*MADS), 1992 [electronic resource] Drug Use Among DC Women Delivering Live Births in DC Hospitals United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse 2008-12-15 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 1998 ICPSR 2347 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. The Washington, DC, Metropolitan Area Drug Study (DC*MADS) was conducted in 1991, and included special analyses of homeless and transient delivering live births in the DC hospitals. DC*MADS was undertaken to assess the full extent of the drug problem in one metropolitan area. The study was comprised of 16 separate studies that focused on different sub-groups, many of which are typically not included or are underrepresented in household surveys. The DC*MADS: Drug Use Among Women Delivering Livebirths in DC Hospitals was designed to examine the nature and extent of drug use among women delivering live births in eight Washington, DC, hospitals participating in the study. Data from the questionnaires include prenatal care, health problems during pregnancy, pregnancy drug use history, needle use, polysubstance use, patterns of use, respondent's general experiences with drug use, including perceptions of the risks and consequences of use, occurrence of psychological and emotional problems, income and insurance coverage, treatment experiences, and maternal and infant outcomes. Medical records were abstracted from the women and their infants to document medical problems. Abstracted data on the mothers included demographics, discharge diagnoses, disposition at discharge, and results of urine screens. Abstracted data on infants included delivery information, status at discharge, discharge diagnoses/procedures, and first urine toxicology screen results. Cf.: http://dx.doi.org/10.3886/ICPSR02347.v2 alcohol consumption icpsr cocaine icpsr demographic characteristics icpsr drug testing icpsr drug use icpsr drugs icpsr hallucinogens icpsr health care access icpsr alcohol icpsr heroin icpsr infants icpsr inhalants icpsr insurance coverage icpsr live births icpsr marijuana icpsr mental health icpsr population characteristics icpsr pregnancy icpsr prenatal care icpsr reproductive history icpsr sedatives icpsr smoking icpsr stimulants icpsr substance abuse treatment icpsr tobacco use icpsr tranquilizers icpsr urban population icpsr women icpsr ICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice System NAHDAP I. National Addiction and HIV Data Archive Program SAMHDA VI. Washington, DC, Metropolitan Area Drug Study (DC*MADS) ICPSR XVI.A. Social Indicators, United States NACJD XI. Drugs, Alcohol, and Crime RCMD V. Health and Well-Being United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse Inter-university Consortium for Political and Social Research. ICPSR (Series) 2347 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR02347.v2 nmm 22 4500 ICPSR06128 MiAaI m f a u cr mn mmmmuuuu 130521s1993 miu f a eng d (MiAaI)ICPSR06128 MiAaI MiAaI National Household Survey on Drug Abuse, 1991 [electronic resource] United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse 2008-08-05 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 1993 ICPSR 6128 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. This series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, anabolic steroids, and tobacco among members of United States households aged 12 and older. Data are also provided on treatment for drug use and on illegal activities related to drug use. Questions include age at first use, as well as lifetime, annual, and past-month usage for the following drug classes: cannabis, inhalants, cocaine, hallucinogens, heroin, alcohol, tobacco, and nonmedical use of psychotherapeutics. Respondents were also asked about problems resulting from their use of drugs, alcohol, and tobacco, their perceptions of the risks involved, insurance coverage, and personal and family income sources and amounts. Demographic data include gender, race, ethnicity, educational level, job status, income level, household composition, and population density. Cf.: http://dx.doi.org/10.3886/ICPSR06128.v2 demographic characteristics icpsr drug abuse icpsr drug use icpsr drugs icpsr hallucinogens icpsr heroin icpsr households icpsr inhalants icpsr marijuana icpsr methamphetamine icpsr prescription drugs icpsr sedatives icpsr smoking icpsr stimulants icpsr alcohol abuse icpsr alcohol consumption icpsr amphetamines icpsr barbiturates icpsr cocaine icpsr crime icpsr substance abuse icpsr substance abuse treatment icpsr tobacco use icpsr tranquilizers icpsr youths icpsr NAHDAP I. National Addiction and HIV Data Archive Program RCMD I. Crime SAMHDA I. National Survey on Drug Use and Health (NSDUH) NACJD XI. Drugs, Alcohol, and Crime ICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice System RCMD V. Health and Well-Being United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse Inter-university Consortium for Political and Social Research. ICPSR (Series) 6128 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR06128.v2 nmm 22 4500 ICPSR02155 MiAaI m f a u cr mn mmmmuuuu 130521s1998 miu f a eng d (MiAaI)ICPSR02155 MiAaI MiAaI Washington, DC, Metropolitan Area Drug Study (DC*MADS), 1991 [electronic resource] Household and Non-Household Populations United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse 2008-07-16 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 1998 ICPSR 2155 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. The DC Metropolitan Area Drug Study (DC*MADS) was conducted in 1991, and included special analyses of homeless and transient populations and of women delivering live births in the DC hospitals. DC*MADS was undertaken to assess the full extent of the drug problem in one metropolitan area. The study was comprised of 16 separate studies that focused on different sub-groups, many of which are typically not included or are under-represented in household surveys. The DC*MADS: Household and Non-household Populations examines the prevalence of tobacco, alcohol, and drug use among members of household and non-household populations aged 12 and older in the District of Columbia Metropolitan Statistical Area (DC MSA). The study also examines the characteristics of three drug-abusing sub-groups: crack-cocaine, heroin, and needle users. The household sample was drawn from the 1991 National Household Survey on Drug Abuse (NHSDA). The non-household sample was drawn from the DC*MADS Institutionalized and Homeless and Transient Population Studies. Data include demographics, needle use, needle-sharing, and use of tobacco, alcohol, cocaine, crack, inhalants, marijuana, hallucinogens, heroin, sedatives, stimulants, psychotherapeutics (non-medical use), tranquilizers, and analgesics. Cf.: http://dx.doi.org/10.3886/ICPSR02155.v3 alcohol icpsr cocaine icpsr crack cocaine icpsr demographic characteristics icpsr drug abuse icpsr drug use icpsr hallucinogens icpsr heroin icpsr homeless persons icpsr inhalants icpsr marijuana icpsr sedatives icpsr smoking icpsr stimulants icpsr tranquilizers icpsr NACJD XI. Drugs, Alcohol, and Crime ICPSR XVI.A. Social Indicators, United States RCMD V. Health and Well-Being NAHDAP I. National Addiction and HIV Data Archive Program SAMHDA VI. Washington, DC, Metropolitan Area Drug Study (DC*MADS) ICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice System United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse Inter-university Consortium for Political and Social Research. ICPSR (Series) 2155 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR02155.v3 nmm 22 4500 ICPSR02346 MiAaI m f a u cr mn mmmmuuuu 130521s1998 miu f a eng d (MiAaI)ICPSR02346 MiAaI MiAaI Washington, DC, Metropolitan Area Drug Study (DC*MADS), 1991 [electronic resource] Homeless and Transient Population United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse 2008-07-24 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 1998 ICPSR 2346 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. The DC Metropolitan Area Drug Study (DC*MADS) was conducted in 1991, and included special analyses of homeless and transient populations and of women delivering live births in the DC hospitals. DC*MADS was undertaken to assess the full extent of the drug problem in one metropolitan area. The study was comprised of 16 separate studies that focused on different sub-groups, many of which are typically not included or are underrepresented in household surveys. The Homeless and Transient Population study examines the prevalence of illicit drug, alcohol, and tobacco use among members of the homeless and transient population aged 12 and older in the Washington, DC, Metropolitan Statistical Area (DC MSA). The sample frame included respondents from shelters, soup kitchens and food banks, major cluster encampments, and literally homeless people. Data from the questionnaires include history of homelessness, living arrangements and population movement, tobacco, drug, and alcohol use, consequences of use, treatment history, illegal behavior and arrest, emergency room treatment and hospital stays, physical and mental health, pregnancy, insurance, employment and finances, and demographics. Drug specific data include age at first use, route of administration, needle use, withdrawal symptoms, polysubstance use, and perceived risk. Cf.: http://dx.doi.org/10.3886/ICPSR02346.v2 smoking icpsr stimulants icpsr substance abuse treatment icpsr urban population icpsr substance abuse treatment icpsr homeless persons icpsr inhalants icpsr living arrangements icpsr marijuana icpsr heroin icpsr employment icpsr urban population icpsr demographic characteristics icpsr drug abuse icpsr drug related crimes icpsr drug use icpsr drugs icpsr crack cocaine icpsr arrests icpsr hallucinogens icpsr health insurance icpsr mental health icpsr mental health treatment icpsr methamphetamines icpsr cocaine icpsr pregnancy icpsr prescription drugs icpsr sedatives icpsr physical health icpsr population characteristics icpsr NAHDAP I. National Addiction and HIV Data Archive Program NACJD XI. Drugs, Alcohol, and Crime SAMHDA VI. Washington, DC, Metropolitan Area Drug Study (DC*MADS) ICPSR XVI.A. Social Indicators, United States RCMD V. Health and Well-Being ICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice System United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse Inter-university Consortium for Political and Social Research. ICPSR (Series) 2346 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR02346.v2 nmm 22 4500 ICPSR06845 MiAaI m f a u cr mn mmmmuuuu 130521s1997 miu f a eng d (MiAaI)ICPSR06845 MiAaI MiAaI National Household Survey on Drug Abuse, 1982 [electronic resource] United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse 2008-06-18 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 1997 ICPSR 6845 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. This series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, tobacco, and nonmedical use of prescription drugs among members of United States households aged 12 and older. Questions include age at first use, as well as lifetime, annual, and past-month usage for the following drug classes: cannabis, cocaine, hallucinogens, heroin, alcohol, tobacco, and nonmedical use of prescription drugs, including psychotherapeutics. Respondents were also asked about problems resulting from their use of drugs, alcohol, and tobacco, their perceptions of the risks involved, and personal and family income sources and amounts. Half of the respondents were asked questions regarding substance use by close friends. Demographic data include gender, race, age, ethnicity, educational level, job status, income level, veteran status, household composition, and population density. Youth respondents were also asked about time spent on homework and leisure activities. Cf.: http://dx.doi.org/10.3886/ICPSR06845.v2 alcohol icpsr drugs icpsr hallucinogens icpsr heroin icpsr households icpsr marijuana icpsr methamphetamine icpsr prescriptions drugs icpsr sedatives icpsr smoking icpsr stimulants icpsr alcohol abuse icpsr substance abuse icpsr substance abuse treatment icpsr tobacco use icpsr tranquilizers icpsr youths icpsr alcohol consumption icpsr amphetamines icpsr barbiturates icpsr cocaine icpsr demographic characteristics icpsr drug abuse icpsr drug use icpsr NAHDAP I. National Addiction and HIV Data Archive Program RCMD I. Crime NACJD XI. Drugs, Alcohol, and Crime ICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice System SAMHDA I. National Survey on Drug Use and Health (NSDUH) RCMD V. Health and Well-Being United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse Inter-university Consortium for Political and Social Research. ICPSR (Series) 6845 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR06845.v2 nmm 22 4500 ICPSR06843 MiAaI m f a u cr mn mmmmuuuu 130521s1998 miu f a eng d (MiAaI)ICPSR06843 MiAaI MiAaI National Household Survey on Drug Abuse, 1979 [electronic resource] United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse 2008-06-18 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 1998 ICPSR 6843 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. This series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, tobacco, and nonmedical use of prescription drugs among members of United States households aged 12 and older. Questions include age at first use, as well as lifetime, annual, and past-month usage for the following drug classes: cannabis, cocaine, hallucinogens, heroin, inhalants, alcohol, tobacco, nonmedical use of prescription drugs including psychotherapeutics, and polysubstance use. Respondents were also asked about their knowledge of drugs, perceptions of the risks involved, population movement, and sequencing of drug use. Fifty-seven percent of respondents were asked specific questions about their perceptions of the consequences of marijuana and alcohol use. The other 43 percent were asked about heroin use among friends. Demographic data include gender, race, age, ethnicity, marital status, educational level, job status, income level, and household composition. Cf.: http://dx.doi.org/10.3886/ICPSR06843.v3 tranquilizers icpsr youths icpsr tobacco use icpsr alcohol icpsr alcohol abuse icpsr alcohol consumption icpsr amphetamines icpsr barbiturates icpsr cocaine icpsr demographic characteristics icpsr drug abuse icpsr drug use icpsr drugs icpsr hallucinogens icpsr heroin icpsr households icpsr inhalants icpsr marijuana icpsr methamphetamine icpsr prescription drugs icpsr sedatives icpsr smoking icpsr stimulants icpsr substance abuse icpsr substance abuse treatment icpsr NACJD XI. Drugs, Alcohol, and Crime NAHDAP I. National Addiction and HIV Data Archive Program RCMD I. Crime SAMHDA I. National Survey on Drug Use and Health (NSDUH) ICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice System RCMD V. Health and Well-Being United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse Inter-university Consortium for Political and Social Research. ICPSR (Series) 6843 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR06843.v3